Login / Signup

Open data on industry payments to healthcare providers reveal potential hidden costs to the public.

Jorge MejiaAmanda F MejiaFranco Pestilli
Published in: Nature communications (2019)
Healthcare industry players make payments to medical providers for non-research expenses. While these payments may pose conflicts of interest, their relationship with overall healthcare costs remains largely unknown. In this study, we linked Open Payments data on providers' industry payments with Medicare data on healthcare costs. We investigated 374,766 providers' industry payments and healthcare costs. We demonstrate that providers receiving higher amounts of industry payments tend to bill higher drug and medical costs. Specifically, we find that a 10% increase in industry payments is associated with 1.3% higher medical and 1.8% higher drug costs. For a typical provider, for example, a 10% or $25 increase in annual industry payments would be associated with approximately $1,100 higher medical costs and $100 higher drug costs. Furthermore, the association between payments and healthcare costs varies markedly across states and correlates with political leaning, being stronger in more conservative states.
Keyphrases
  • healthcare
  • minimally invasive
  • electronic health record
  • primary care
  • gene expression
  • mental health
  • emergency department
  • health information
  • dna methylation
  • adverse drug
  • high resolution